Related Experiment Video
Updated: Mar 1, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Cardiomyopathies with Mixed and Inapparent Morphological Features in Cardiac Troponin I3 Mutation
Dae-Won Sohn1, Hyung-Kwan Kim1, Yong-Jin Kim1
1Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Insights
A novel cardiac troponin I3 mutation causes mixed hypertrophic cardiomyopathy and left ventricular non-compaction features in a single family. This genetic finding highlights the complex presentation of cardiomyopathies and potential for early, unexpected deaths.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Molecular Biology
Background:
- Genetic mutations in sarcomere proteins are known to cause various cardiomyopathies.
- Mixed clinical and morphological features of different cardiomyopathies within a single patient are less understood.
- Previous studies have not fully appreciated the spectrum of presentations for single gene mutations.
Purpose of the Study:
- To investigate a novel mutation in cardiac troponin I3 (Arg186Gly).
- To describe the mixed phenotypic expression of hypertrophic cardiomyopathy and left ventricular non-compaction in a family with this mutation.
- To highlight the potential for early mortality associated with this genetic variant.
Main Methods:
- Genetic sequencing to identify novel mutations in sarcomere protein genes.
- Echocardiography and cardiac magnetic resonance imaging to assess cardiac morphology.
- Family history review to document clinical outcomes and mortality.
Main Results:
- A novel Arg186Gly mutation in the cardiac troponin I3 gene was identified.
- Two family members presented with overlapping features of hypertrophic cardiomyopathy and left ventricular non-compaction.
- These mixed cardiomyopathy features were not clearly defined for each individual type.
- Four family members experienced premature deaths before age 30.
Conclusions:
- A novel cardiac troponin I3 mutation can lead to a mixed phenotype of hypertrophic cardiomyopathy and left ventricular non-compaction.
- This genetic mutation is associated with significant morbidity and premature mortality within affected families.
- Further research is needed to understand the mechanisms underlying the variable and mixed presentations of cardiomyopathies.
Abstract:
The fact that different types of cardiomyopathies can be manifested by the same sarcomere protein gene mutation in a single family is well known. However, mixed features of different types of cardiomyopathies in a single patient have not been well appreciated. We identified a novel mutation in cardiac troponin I3 (Arg186Gly) in the present case, and two of the family members showed mixed morphologic features of hypertrophic cardiomyopathy and left ventricular non-compaction. Moreover, both the features of cardiomyopathies were not apparent for each type of cardiomyopathy. In the patient's family, four other members had unexpected deaths before the age of 30.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy

